Abbas Ardehali
Directeur/Membre du Conseil chez BIOM'UP
Postes actifs de Abbas Ardehali
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BIOM'UP | Directeur/Membre du Conseil | 30/01/2018 | - |
Medcura, Inc.
 Medcura, Inc. Medical SpecialtiesHealth Technology Medcura, Inc. develops novel line of hemostatic and wound treatment products. The firm?s products include vascular gel-e, nuisance bleed, chronic wound, and surgical gel-e. The company was founded by Matthew Dowling in January 2013 and is headquartered in Riverdale, MD. | Directeur/Membre du Conseil | 01/06/2023 | - |
Historique de carrière de Abbas Ardehali
Formation de Abbas Ardehali
| Emory University School of Medicine | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| France | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Biom'Up SA
 Biom'Up SA Medical SpecialtiesHealth Technology Biom'Up SA engages in the development of hemostatic product composed of patent-protected biopolymers. Its products include Hemoblast Bellows and Hemosnow. The company was founded by Patricia Forest, Sylvain Picot and Christian Gagnieu on February 21, 2005 and is headquartered in Lyon, France. | Health Technology |
Medcura, Inc.
Medcura, Inc. Medical SpecialtiesHealth Technology Medcura, Inc. develops novel line of hemostatic and wound treatment products. The firm?s products include vascular gel-e, nuisance bleed, chronic wound, and surgical gel-e. The company was founded by Matthew Dowling in January 2013 and is headquartered in Riverdale, MD. | Health Technology |
- Bourse
- Insiders
- Abbas Ardehali
- Expérience
